What is Plegridy? What is Plegridy used for?
Peginterferon beta-1a (Plegridy) is a protein produced by recombinant DNA technology using genetically engineered Chinese Hamster Ovary Cells into which the human interferon beta genes have been introduced. It is used for treating multiple sclerosis (MS). It differs from interferon beta-1a by having polyethylene glycol attached to the interferon molecules (peglated) that allow the interferon to remain in the body for longer times thus allowing less frequent dosing. Interferon beta-1a is designed to be identical to interferon beta that is naturally produced by various cells in the body. Interferon beta has antiviral properties and plays a role in regulating the immune response. The exact mechanism by which interferon beta-1a works in the body to treat MS is not known. Interferon beta-1a does not cure MS. Rather it helps to decrease the number of flare-ups and slows the occurrence of some of the physical disability that commonly occurs in the disease. Plegridy works in the same way and has similar side effects as other interferon beta-1a products such as Avonex and Rebif. However, it is given every 14 days versus once weekly or 3 times per week injections. The FDA approved Plegridy in August, 2014.
What brand names are available for Plegridy?
Is Plegridy available as a generic drug?
Do I need a prescription for Plegridy?
What are the side effects of Plegridy?
The most common side effects of interferon beta-1a are:
- injection site reactions,
- flu-like symptoms,
- muscle aches,
- diarrhea, and
Flu-like symptoms are commonly experienced when patients first start taking interferon beta-1a. These symptoms can be managed with over-the-counter pain and fever reducers, and usually decrease or go away over time.
What is the dosage for Plegridy?
The recommended dose of Plegridy is 125 mcg injected under the skin (subcutaneously) every 14 days.
Treatment is started at the lower dose of 63 mcg followed by a second injection of 94 mcg injection on day 15. The full dose of 125 mcg is administered for the third dose on day 29 and every 14 days thereafter.
The best sites to inject are the areas of the body that usually have more fatty tissue such as the thigh, back of the upper arm, and stomach. To avoid injury, patients are advised to change or rotate the injection sites.
Which drugs or supplements interact with Plegridy?
- Your Child Is Sick. Do You Call Your Doctor or Head to the ER?
- Mental Health Care Shortage Could Play Role in U.S. Youth Suicides
- Shopping Black Friday for TVs, Furniture? Don't Forget the Tip-Over Kit
- Keeping Thanksgiving Day Kitchens Safe for the Whole Family
- All the Flavor, Better Health: Holiday Dinner Ingredient Swaps That Work
- More Health News »
Is Plegridy safe to take if I'm pregnant or breastfeeding?
Use of peginterferon beta-1a has not been adequately evaluated in pregnant women. Due to the lack of conclusive safety data, peginterferon beta-1a should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Peginterferon beta-1a is classified as FDA pregnancy risk category C. This designation indicates fetal harm from the drug has been shown in animal studies, but information on effects in pregnant women is not clear.
It is not known if peginterferon beta-1a is excreted in breast milk. As many drugs enter breast milk and can potentially cause harm to the nursing infant, peginterferon beta-1a should be used cautiously in nursing mothers.
What else should I know about Plegridy?
What preparations of Plegridy are available?
Plegridy is available in prefilled pens or syringes for subcutaneous injection.
Injection: 125 mcg/0.5 ml solution in single-dose prefilled syringe or single-dose prefilled pen.
Injection starter pack: containing 63 mcg/0.5 ml and 94 mcg/0.5 ml solution in single-dose prefilled pens or syringes.
How should I keep Plegridy stored?
Preferably peginterferon beta-1a should be stored refrigerated at a temperature from 2 C to 8 C (36 F to 46 F). Peginterferon beta-1a should be warmed to room temperature before injecting. If refrigeration is not available, peginterferon beta-1a can be stored from 2 C to 25 C (36 F to 77 F) for up to 30 days.
Peginterferon beta-1a (Plegridy) is a protein produced by genetically engineered cells used in the treatment of multiple sclerosis by mimicking the human protein and reducing physical disability. Side effects, drug interactions, and use during pregnancy should be reviewed prior to taking any medication.
Multimedia: Slideshows, Images & Quizzes
What Is Multiple Sclerosis? MS Symptoms, Causes, Diagnosis
MS is an autoimmune disease that attacks the nerves of the central nervous system. Learn about multiple sclerosis (MS) causes,...
Multiple Sclerosis (MS) Quiz: Test Your Medical IQ
Multiple Sclerosis is a debilitating neurological condition. Take the MS Quiz to test your knowledge of the causes, symptoms,...
Picture of Multiple Sclerosis Symptoms
Symptoms of multiple sclerosis may be single or multiple and may range from mild to severe in intensity and short to long in...
Related Disease Conditions
Multiple Sclerosis (MS)
Multiple sclerosis or MS is an autoimmune disorder in which brain and spinal cord nerve cells become demyelinated. This damage results in symptoms that may include numbness, weakness, vertigo, paralysis, and involuntary muscle contractions. Different forms of MS can follow variable courses from relatively benign to life-threatening. MS is treated with disease-modifying therapies. Some MS symptoms can be treated with medications.
Multiple Sclerosis (MS) Symptoms and Treatments
Multiple sclerosis (MS) symptoms vary from person to person and can last for days to months without periods of remission. Symptoms of MS include sexual problems and problems with the bowel, bladder, eyes, muscles, speech, swallowing, brain, and nervous system. The early symptoms and signs of multiple sclerosis usually start between ages 20-40. MS in children, teens, and those over age 40 is rare. Treatment options for multiple sclerosis vary depending on the type and severity of symptoms. Medications may be prescribed to manage MS symptoms.
Is Multiple Sclerosis (MS) Contagious?
Multiple sclerosis, or MS, is a degenerative disease of the covering around the nerves in the central nervous system (CNS). Researchers and doctors don't know the exact cause, but many theorize that it may be due to environmental triggers, an autoimmune disease, and viruses (infections). Symptoms and signs of MS include vision changes, paralysis, vertigo, heat intolerance, slurred speech, sexual dysfunction, and urinary incontinence (the inability to urinate). There's no vaccine or cure for MS, but the progression and symptoms of the disease can be treated.
Hepatitis C Cure (Symptoms, Transmission, Treatments, and Cost)
Hepatitis is inflammation of the liver. There are a variety of toxins, diseases, illicit drugs, medications, bacterial and viral infections, and heavy alcohol use can case inflammation of the liver. Hepatitis C viral infection (HCV) is one type of hepatitis. According to the CDC, in 2014 there were an estimated 30,500 cases of acute hepatitis C infections in the US. An estimated 2.7-3.9 million people in the US have chronic hepatitis C. The virus is spread from person-to-person via blood-to-blood contact. Symptoms of HCV infection include joint pain, jaundice, dark urine, nausea, fatigue, fever, loss of appetites, clay colored stool. Hepatitis C can be cured with medications in most people. There is no vaccine against the hepatitis C virus.
Alternative Treatment (CAM) for MS
The term alternative therapy, in general, is used to describe any medical treatment or intervention that has not been scientifically documented or identified as safe or effective for a specific condition. Alternative therapy encompasses a variety of disciplines that range from diet and exercise to mental conditioning to lifestyle changes.
Treatment & Diagnosis
Medications & Supplements
Subscribe to MedicineNet's General Health Newsletter
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.